Minimal residual disease - Insights
Get full-spectrum minimal residual disease testing options, all from one laboratory, with experts to support testing decisions and results.
Committed to sharing knowledge The exchange of knowledge is a founding principle of Mayo Clinic. We provide a wide range of in-person, live online, and
The Value Stream of an Outreach Program - Insights
When considering the outreach laboratory value stream, it is important to remember that without quality, there is no value. Through identifying sources for error or non-value-added activities, the hospital laboratory outreach program can...
Practical Approaches to Outreach Marketing - Insights
Marketing is an essential discipline of any successful laboratory outreach program. While specific marketing goals and audiences will differ for every program, most of them will certainly involve driving awareness and growth. A strong...
Monitoring Hurricane Milton - Insights
Hurricane Milton is approaching the west coast of Florida and is anticipated to make landfall Wednesday. We continue to monitor and track the situation with our logistics partners to minimize challenges.
Skip to Content MayoACCESS MayoLINK...
Due to a pending winter storm affecting the FedEx hub in Memphis, Tennessee, and the UPS hub in Louisville, Kentucky, Mayo Clinic Laboratories will monitor and track the situation with our logistics partners to minimize challenges. Read...
Lab Medicine Rounds - Insights
A Mayo Clinic podcast for physicians, laboratory professionals, and students hosted by Justin Kreuter, M.D., (the Bow Tie Bandit of Blood) and featuring trending topics from subject-matter experts. Note: Podcasts will not play back on...
RNA test identifies large B-cell lymphoma subtypes: Lisa Rimsza, M.D. - Insights
Lisa Rimsza, M.D., explains how Mayo Clinic Laboratories' unique PM3CX test can accurately determine subtypes of large B-cell lymphoma. Precise diagnosis is critical to choosing appropriate chemotherapy.
Assay identifies most known membranous nephropathy antigens: Sanjeev Sethi, M.D., Ph.D. - Insights
Sanjeev Sethi, M.D., Ph.D., explains how Mayo Clinic Laboratories' new mass spectrometry test (Mayo ID: MSMN) identifies most antigens now known to cause membranous nephropathy. Precise identification of antigens is important for optimal...